Status:
COMPLETED
The T2D Profile - Studies of the Omics Profile in Type 2 Diabetes
Lead Sponsor:
Göteborg University
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
50-65 years
Brief Summary
The T2D Profile study examines the longitudinal molecular profiles of newly diagnosed type 2 diabetes (T2D), before and during guideline-based diabetes treatment.
Detailed Description
The study included a total of 3 visits: At baseline and after 1 and 3 months of diabetes treatment according to standard of care. Visits included clinical examinations, questionnaires and clinical che...
Eligibility Criteria
Inclusion
- Signed informed consent to participate in the study.
- Age 50-65 years.
- T2D diagnosis (fasting p-glucose ≥7.0 mmol/L or an oral glucose tolerance test 2 hour p-glucose ≥11.1 mmol/L \[or ≥12.2 mmol/L if measured capillary\] at two separate occasions).
Exclusion
- Diabetes medication before study start.
- Severe hyperglycemia requiring hospitalization or immediate insulin treatment, as judged by the investigator.
- Presence of any clinically significant disease which, in the opinion of the investigator, may interfere with the subject´s ability to participate in the study.
- Any major surgical procedure or trauma within 4 weeks of the first study visit.
Key Trial Info
Start Date :
June 15 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2018
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT06905717
Start Date
June 15 2016
End Date
December 31 2018
Last Update
April 1 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.